Hiv

Reading File
Asking for Preferences
Finding Sources
Finding Sources
Searching PubMed

"HIV" AND "pathophysiology"

Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
I now have rich, authoritative content from multiple sources. Let me compile the comprehensive answer.

HIV: Overview and Pathophysiology

What is HIV?

HIV (Human Immunodeficiency Virus) is an RNA retrovirus belonging to the genus Lentivirus. There are two types: HIV-1 (the dominant global form) and HIV-2 (mostly confined to West Africa). Left untreated, HIV progressively destroys cellular immunity, eventually resulting in AIDS (Acquired Immunodeficiency Syndrome).
As of 2022, approximately 39 million people worldwide were living with HIV, with ~67% in Sub-Saharan Africa. Antiretroviral therapy (ART) has transformed HIV from a fatal illness into a manageable chronic condition, with life expectancy now approaching that of the general population in treated individuals.
  • Harrison's Principles of Internal Medicine 22e (2025)

The Virus

HIV is a retrovirus. Its key structural and functional features:
ComponentRole
gp120 (surface glycoprotein)Binds CD4 receptor on host T cells
gp41 (transmembrane glycoprotein)Mediates membrane fusion
Reverse transcriptaseConverts viral RNA to DNA (essential drug target)
IntegraseIntegrates viral DNA into host genome
ProteaseCleaves polyprotein precursors into mature virions
CCR5 / CXCR4 (host co-receptors)Required alongside CD4 for viral entry

The HIV Life Cycle (6 Steps)

  1. Attachment - gp120 binds CD4 on T cells/macrophages; co-receptor (CCR5 or CXCR4) binding follows
  2. Fusion - gp41 drives the viral envelope to fuse with the host cell membrane
  3. Reverse transcription - Viral RNA is converted to double-stranded DNA by reverse transcriptase (the most exploited drug target)
  4. Integration - Viral DNA is inserted into the host genome by integrase (forming the "provirus")
  5. Transcription & Translation - Host cell machinery transcribes viral genes into mRNA and viral proteins
  6. Assembly, budding & maturation - New virions assemble and bud from the cell; protease cleaves polyproteins into functional units
Each step is a drug target, forming the basis of modern ART classes (NRTIs, NNRTIs, INSTIs, PIs, entry inhibitors).
  • Kaplan & Sadock's Comprehensive Textbook of Psychiatry

Primary Target Cells

HIV infects cells expressing CD4:
  • CD4+ T helper cells (main target - progressive depletion drives immunodeficiency)
  • Macrophages (serve as a long-lived viral reservoir)
  • Dendritic cells (aid in viral dissemination to lymph nodes)

Phases of Disease and Pathogenesis

1. Acute Phase (Primary Infection, weeks 1-4)

  • After mucosal exposure, the virus undergoes an initial "eclipse phase" - undetectable in plasma for days
  • Virus replicates in mucosal CD4+ T cells, draining lymph nodes, then disseminates widely
  • GALT (gut-associated lymphoid tissue) is massively seeded - memory CD4+ T cells there are infected and depleted by direct viral killing and activation-induced apoptosis
  • A burst of high-level plasma viremia occurs
  • Acute HIV syndrome appears: flu-like illness (fever, lymphadenopathy, rash, myalgia)
  • Viral RNA peaks, then CD8+ T cell responses partially suppress viremia

2. Latent (Chronic) Phase (months to years)

  • Low-level viral replication continues in lymphoid tissues
  • CD4+ count slowly declines from normal (~500-1500 cells/µL) toward ~350 cells/µL
  • Patient may be asymptomatic
  • Persistent immune activation and chronic inflammation continue to drive cell death
  • HIV establishes latent reservoirs in resting memory T cells and macrophages - these cannot be cleared by current ART

3. Advanced Disease / AIDS

  • CD4+ count falls below 200 cells/µL (AIDS-defining threshold in the USA)
  • Susceptibility to opportunistic infections (OIs): Pneumocystis jirovecii pneumonia, CMV, Toxoplasma, Mycobacterium avium complex, cryptococcal meningitis
  • AIDS-defining malignancies: Kaposi sarcoma, primary CNS lymphoma, invasive cervical cancer
  • HIV encephalopathy and wasting syndrome
  • Harrison's Principles of Internal Medicine 22e (2025), Cellular and Molecular Immunology (9e)

Mechanisms of CD4+ T Cell Depletion

Several mechanisms operate simultaneously:
  1. Direct cytolysis - viral replication leads to cell lysis during budding
  2. Immune clearance - CD8+ cytotoxic T cells kill HIV-infected cells
  3. Pyroptosis - caspase-1-mediated inflammatory cell death in tissue CD4+ T cells undergoing abortive (non-productive) HIV infection
  4. Activation-induced apoptosis - chronic immune activation drives T cell exhaustion and death
  5. Immune exhaustion - persistent antigen stimulation causes functional T cell dysfunction even before numerical depletion
The result is a quantitative and qualitative failure of CD4+ T cell immunity.
  • Harrison's Principles of Internal Medicine 22e (2025)

Viral Reservoirs - The Cure Problem

HIV establishes long-lived reservoirs that persist despite ART:
ReservoirLifespan
Activated CD4+ T cellsShort-lived
MacrophagesLonger-lived
Follicular helper T cellsLong-lived
Resting memory CD4+ T cells (especially mucosal)Very long-lived - main barrier to cure
Because the proviral DNA in resting memory cells is transcriptionally silent, the immune system cannot recognize and eliminate these cells. ART suppresses viral replication but does not clear these reservoirs. This is why stopping ART leads to viral rebound within weeks.

Why HIV Evades Immunity

  • Extremely high mutation rate - reverse transcriptase lacks proofreading, generating massive genetic diversity
  • Escape from CD8+ T cell and antibody responses by mutating epitopes
  • Downregulation of MHC class I by the Nef protein (reducing CD8+ T cell recognition)
  • Progressive depletion of the very cells (CD4+ T helpers) needed to sustain immune responses
  • Latency in resting memory cells renders the virus invisible to the immune system

Clinical Summary: CD4 Count and Risk

CD4+ CountClinical Status
>500 cells/µLNormal immunity
200-500 cells/µLModerate immune suppression; some OI risk
<200 cells/µLAIDS; high OI risk (PCP, etc.)
<100 cells/µLSevere AIDS; CMV, MAC, cryptococcal risk
<50 cells/µLProfound immunosuppression; CMV retinitis, disseminated MAC

Would you like to go deeper into any specific aspect - such as ART drug classes and mechanisms, opportunistic infections, diagnosis and staging, or HIV and the nervous system?
This is a shared conversation. Sign in to Orris to start your own chat.